J&J Wins Arkansas Supreme Court Battle

The Arkansas Supreme Court tossed out a $1.2 billion judgment against Johnson & Johnson, reversing a lower court verdict that found the company engaged in fraudulent tactics when marketing the antipsychotic drug Risperdal. The high court ruled the state's Medicaid fraud law regulates health care facilities and that drug manufacturers don't fall under its scope. Read the full story

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments